Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic biomarkers for HNSCC using quantitative real‐time PCR and microarray analysis: β‐tubulin isotypes and the p53 interactome

30 Oct 2014

Abstract excerpt

In 2014, more than 40,000 people in the United States will be diagnosed with head and neck squamous cell cancer (HNSCC) and nearly 8400 people will die of the disease (www.cancer.org/acs/groups). Little is known regarding molecular targets that might lead to better therapies and improved outcomes for these patients. The incorporation of taxanes into the standard cisplatin/5-fluouracil initial chemotherapy for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25355403
DOI: 10.1002/cm.21195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers for HNSCC using quantitative real‐time PCR and microarray analysis: β‐tubulin isotypes and the p53 interactomePMID 25355403Read ↗

Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analysesSemantic proximity Read ↗

Is biomarker research advancing in the era of personalized medicine for head and neck cancer?Semantic proximity Read ↗

Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.Semantic proximity Read ↗

Class III β‐tubulin and the cytoskeletal gateway for drug resistance in ovarian cancerSemantic proximity Read ↗

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Class III β-Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized TrialSemantic proximity Read ↗

ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.Semantic proximity Read ↗

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinomaSemantic proximity Read ↗

Clinical implications of biomarkers in head and neck cancer.Semantic proximity Read ↗

Investigation of molecular modulation of taxane response in respiratory tract cancers by differential expression of mitotic spindle associated genesSemantic proximity Read ↗

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinomaSemantic proximity Read ↗

Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.